REGULATORY MECHANISMS OF ANGIOTENSIN-CONVERTING ENZYME 2 AND THEIR SIGNIFICANCE IN THE DEVELOPMENT OF SEVERE COVID-19
DOI:
https://doi.org/10.58395/cvkyan65Keywords:
ACE2, COVID-19, SARS-CoV-2Abstract
From 2019 to the present day, the coronavirus infection COVID-19 continues to be a serious health problem. Scientists and clinicians from all over the world have joined efforts in studying the molecular interaction mechanisms between SARS-CoV-2 and ACE2, including virus-induced changes in ACE2 transcription, expression, and functionalities leading to disruption of basic regulatory pathways for vascular homeostasis, and reprogramming of key proteases, co-receptors and adhesion molecules.
Here, we aimed to clarify the mechanisms and signals that would restore the virus-induced imbalance between destructive and protective effects of ACE2.
Understanding why only certain individuals are predisposed to infection with SARS-CoV-2, and development of severe pathology is at the center of scientific interest, and the strategies for prevention and therapy.
Downloads
References
Zhu N, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (8): 727–733.
Genova SN, Genova N, Pencheva MM, Ivanov A G. A case of severe acute respiratory syndrome coronavirus 2 with acute thrombotic cerebral infarction and generalized thrombosis. Indian J. Case Reports 2021; 7(9): 405-408. https://doi.org/10.32677/ijcr.v7i9.3045
Abd El-Aziz TM, Al-Sabi A, Stockand JD. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19. Signal Transduct Target Ther 2020; 5(1): 258. https://doi.org/10.1038/s41392-020-00374-6
Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?. Clin Chem Lab Med 2020; 58(9): 1415-1422. https://doi.org/10.1515/cclm-2020-0727
Pencheva M, Genova S. SARS-CoV-2 Induced Changes in the Lungs Based on Autopsy Cases. Indian J. Pathology Microbiology 2023; 66:19–19. https://doi.org/10.4103/ijpm.ijpm_734_21.
Genova S, Pencheva M, Uchikov P. Comorbidity and cause of death in the different variants of SARS-COV-2 virus, with contribution of 20 autopsy cases. Probl Infect Parasit Dis 2023; 51(1): 26-36. https://doi.org/10.58395/m27hv064
Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res 2020; 126(10): 1456-1474. https://doi.org/10.1161/CIRCRESAHA.120.317015
Robinson EL, Alkass K, Bergmann O, et al. Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes. J Mol Cell Cardiol 2020; 147: 88-91. https://doi.org/10.1016/j.yjmcc.2020.08.009
Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008; 29(7): 367-374. https://doi.org/10.1016/j.yjmcc.2020.08.009
Schmaier AH. The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. J Clin Invest 2002; 109(8): 1007–1009. https://doi.org/10.1172/JCI15490
Rahman AM, et al. Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans. J Vasc Res 2014; 51(3): 200–208. https://doi.org/10.1159/000362666
Howl J, Payne SJ. Bradykinin receptors as a therapeutic target. Expert Opin Ther Targets 2003; 7(2): 277-285. https://doi.org/10.1517/14728222.7.2.277
Murugesan P, et al. Kinin B1 receptor inhibition with BI113823 reduces inflammatory response, mitigates organ injury, and improves survival among rats with severe sepsis. J Infect Dis 2016; 213(4): 532–540. https://doi.org/10.1093/infdis/jiv426
Sodhi CP, et al. Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPSinduced neutrophil infiltration. Am J Physiol Lung Cell Mol Physiol 2018; 314(1): L17–L31. https://doi.org/10.1152/ajplung.00498.2016
van de Veerdonk FL, Netea MG, van Deuren M, et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife 2020; 9:e57555. https://doi.org/10.7554/eLife.57555
Gouda AS, Mégarbane B. Snake venom-derived bradykinin potentiating peptides: A promising therapy for COVID-19?. Drug Dev Res 2021; 82(1): 38-48. https://doi.org/10.1002/ddr.21732
Zhong JC, et al. Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases. Biochim Biophys Acta Mol Basis Dis 2017; 1863: 1942–1950. https://doi.org/10.1016/j.bbadis.2016.11.007
Zhang ZZ, Wang W, Jin HY, et al. Apelin is a negative regulator of angiotensin Iimediated adverse myocardial remodeling and dysfunction. Hypertension 2017; 70: 1165–1175. https://doi.org/10.1161/HYPERTENSIONAHA.117.10156
Wang W, McKinnie SM, Farhan M, et al. Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System. Hypertension 2016; 68(2): 365-377. https://doi.org/10.1161/HYPERTENSIONAHA.115.06892
Hashimoto T, Perlot T, Rehman A, et a. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012; 487(7408): 477-481. https://doi.org/10.1038/nature11228
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367: 1444–1448. https://doi.org/10.1126/science.abb2762
Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020; 9: 45. https://doi.org/10.1186/s40249-020-00662-x
Sungnak W, Huang N, Bécavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-687. https://doi.org/10.1038/s41591-020-0868-6
Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020; 12: 8. https://doi.org/10.1038/s41368-020-0074-x
Henry BM. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020; 58(7): 1021-1028. https://doi.org/10.1515/cclm-2020-0369
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020; 181(2): 271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052
Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020; 9: 45. https://doi.org/10.1186/s40249-020-00662-x
Banerjee A, El-Sayes N, Budylowski P, et al. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses. iScience 2021; 24(5): 102477. https://doi.org/10.1016/j.isci.2021.102477
Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 2020; 369(6504): 718-724. https://doi.org/10.1126/science.abc6027
Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 2020; 370(6518): 856-860. https://doi.org/10.1126/science.abd2985
Wang K, Chen W, Zhang Z, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 2020; 5(1): 283. https://doi.org/10.1038/s41392-020-00426-x
Clausen TM, Sandoval DR, Spliid CB, et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell 2020; 14: 33. https://doi.org/10.1016/j.cell.2020.09.033
34. Park YJ, Walls AC, Wang Z et al. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Nat Struct Mol Biol 2019; 26(12): 1151-1157. https://doi.org/10.1038/s41594-019-0334-7
Henry BM. et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020; 58(7): 1021-1028. https://doi.org/10.1515/cclm-2020-0369
Zamorano CN, Grandvaux N. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 2020; 9: e61390. https://doi.org/10.7554/eLife.61390
Onabajo OO, Banday AR, Stanifer ML, et al. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat Genet 2020; 52(12):1283-1293. https://doi.org/10.1038/s41588-020-00731-9
Blume C, Jackson CL, Spalluto CM, et al. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat Genet 2021; 53(2): 205-214. https://doi.org/10.1038/s41588-020-00759-x
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Mina Pencheva, Neshka Manchorova_Veleva (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
